Actively Recruiting
Study of Four Medical Devices for Treating Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis in Adults
Led by University Hospital, Clermont-Ferrand · Updated on 2026-06-15
150
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a clinical follow-up study to evaluate four medical devices named NS, NHE, NHG, and PIR. These devices are used in treating acute viral rhinitis, rhinosinusitis, and rhinopharyngitis. The study aims to collect real-life clinical data to confirm the tolerance, safety, and effectiveness of these treatments and to assess their benefit-to-risk ratio. Participants are randomly assigned to one of four groups, each receiving one of the medical devices PIR, NS, NHE, or NHG. The study does not mask the treatment assignment and follows a parallel design. Participants will use the assigned device during the study period, with outcomes measured from day 1 through day 15. During the study, participants will undergo assessments at the start day 1 and follow-up day 15 visits. Researchers will monitor tolerance, effectiveness, quality of life impact, and any device defects throughout this period. The total study participation spans approximately two weeks, during which clinical data will be collected to evaluate the treatment experience and safety.
CONDITIONS
Brief Title
RhinAV_Evaluation of Treatments for Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis
Research Team
L
Lise Laclautre
L
Lise Laclautre
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here